Delivery Order SPE2DB22D1202-SPE2DB25FVAM8
Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Vyvanse 30 mg capsules (quantity 100) with a contract value of $1,163.08. This is a firm fixed price delivery order with an ultimate completion date of July 16, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,337.70 on July 21, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). This firm fixed-price delivery order, which is expected to be completed by July 22, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used in...
- The Defense Logistics Agency awarded a delivery order valued at $1,676.98 to AmerisourceBergen Drug Corp for Vyvanse 50 mg capsules (100 count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside contract represents a firm fixed-price delivery order to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used in military and veteran healthcare systems for the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $1,941.61 to AmerisourceBergen Drug Corp for Vyvanse 60 mg capsules (100 count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used in military and veteran healthcare systems for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for Vyvanse 60 mg capsules (100-count units) with a ceiling value of $1,722.52. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a competitively awarded, non-set-aside procurement. The order is scheduled for ultimate completion on May 28, 2025, with performance based at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,601.50 to AmerisourceBergen Drug Corp for Vyvanse 30 mg capsules (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a non-competitive set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Vyvanse 30 mg capsules (100-count) with a contract value of $1,109.76. This delivery order represents a firm fixed-price transaction executed under a non-competitive, non-set-aside arrangement and carries an ultimate completion date of June 30, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,754.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vyvanse 30 mg capsules (100 count) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for the supply of Vyvanse 20 mg capsules in quantities of 100 units, with a ceiling value of $1,218.54. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of May 16, 2025. The award leverages AmerisourceBergen's extensive pharmaceutical supply capabilities and its established presence as a critical federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Vyvanse 50 mg capsules (100 count units) with a ceiling value of $1,441.35. This is a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive, non-set-aside award. The contract is performed from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under...